Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence

Circulation Journal

Volumn 71, Issue 5, 2007, Pages 709-715

  Fukazawa, Ryuji ^a,b   Ikegam, Ei ^a   Watanabe, Miki ^a   Hajikano, Miharu ^a   Kamisago, Mitsuhiro ^a   Katsube, Yasuhiro ^a   Yamauchi, Hitoshi ^a   Ochi, Masami ^a   Ogawa, Shunichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

Aneurysm; Atherosclerosis; Kawasaki disease; Senescence

Indexed keywords

ACETYLSALICYLIC ACID; CARTEOLOL; CD31 ANTIGEN; DIPYRIDAMOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GALACTOSIDASE; HEPARIN DERIVATIVE; IMMUNOGLOBULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPRANOLOL DERIVATIVE; STEROID; TICLOPIDINE; ULINASTATIN; VASCULAR CELL ADHESION MOLECULE 1; WARFARIN;

ARTICLE; CELL AGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BYPASS GRAFT; DNA MICROARRAY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; SENESCENCE; VASCULAR ENDOTHELIUM;

AGING; BETA-GALACTOSIDASE; CARDIAC SURGICAL PROCEDURES; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; CORONARY ARTERY BYPASS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; STAINING AND LABELING;

EID: 34247606564     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.709     Document Type: Article

References (30)

1. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001; 107: E33.
2. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 2001; 107: 1095-1099.
3. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: With reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol 2001; 22: 138-142.
4. Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: Association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005; 111: 38-43.
5. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
6. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
7. Sata M. Molecular strategies to treat vascular diseases. Circ J 2002; 67: 983-991.
8. Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res 2001; 89: 793-798.
9. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation 2002; 105: 1541-1544.
10. Minamino T, Miyauchi H, Yoshida T, Tateno K, Komuro I. The role of vascular cell senescence in atherosclerosis: Antisenescence as a novel therapeutic strategy for vascular aging. Curr Vasc Pharmacol 2004; 2: 141-148.
11. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: Immunohistochemical study. Circulation 2000; 101: 2935-2941.
12. Ikeda U, Matsui K, Murakami Y, Shimada K. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol 2002; 25: 143-147.
13. Bursill CA, Channon KM, Greaves DR. The role of chemokines in atherosclerosis: Recent evidence from experimental models and population genetics. Curr Opin Lipidol 2004; 15: 145-149.
14. Yamauchi H, Ochi M, Fujii M, Hinokiyama K, Ohmori H, Sasaki T, et al. Optimal time of surgical treatment for Kawasaki coronary artery disease. J Nippon Med Sch 2004; 71: 279-286.
15. Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, Uchikoba Y, et al. Estimation of myocardial hemodynamics before and after intervention in children with kawasaki disease. J Am Coll Cardiol 2004; 43: 653-661.
16. Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 2000; 42: 470-475.
17. Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 1979; 43: 633-643.
18. Terai M, Jibiki T, Harada A, Terashima Y, Yasukawa K, Tateno S, et al. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 1999; 65: 566-572.
19. Miura M, Garcia FL, Crawford SE, Rowley AH. Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease. Pediatr Infect Dis J 2004; 23: 931-936.
20. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995; 25: S9-S12.
21. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 2005; 69: 1484-1489.
22. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr, et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005; 112: 1113-1120.
23. Iwai N, Kajimoto K, Kokubo Y, Okayama A, Miyazaki S, Nonogi H, et al. Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J 2006; 70: 805-809.
24. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol 2005; 46: 1496-1502.
25. Han KH, Hong K-H, Park J-H, Ko J, Kang D-H, Choi K-J, et al. C-Reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 2004; 109: 2566-2571.
26. Asano T, Ogawa S. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: The anti-inflammatory effect of gamma globulin therapy. Scand J Immunol 2000; 51: 98-103.
27. Deng Y, Li T, Xiang H, Chang Q, Li C. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 2003; 22: 34-39.
28. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94: 2103-2106.
29. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 1986; 250: H1145-H1149.
30. Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 2005; 26: 782-786.